Serum-free light-chain assay: clinical utility and limitations.

Serum-free light-chain assay: clinical utility and limitations.

Item
http://www.wikidata.org/entity/Q38184529
Pathophysiology and treatment of cardiac amyloidosis.Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ RatioAnalytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases.Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies:  High False-Positive Rate.Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosisAntibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by ExosomesPrognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
P2860

Serum-free light-chain assay: clinical utility and limitations.

Item
http://www.wikidata.org/entity/Q38184529
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Serum-free light-chain assay: clinical utility and limitations.
@en
type
label
Serum-free light-chain assay: clinical utility and limitations.
@en
prefLabel
Serum-free light-chain assay: clinical utility and limitations.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Serum-free light-chain assay: clinical utility and limitations.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698